Description
Class: Blend of two synthetic peptides: BPC-157 (pentadecapeptide) and TB-500 (thymosin beta-4 related peptide).
Mechanism: See the individual BPC-157 and TB-500 listings. Published literature reports effects on angiogenic signalling and actin-dependent cell migration in preclinical models.
Specification: Lyophilized powder, ≥99% purity. Requires reconstitution. Each vial contains 10 mg BPC-157 and 10 mg TB-500.
Storage: Store lyophilized at −20°C. Protect from light.
For laboratory research use only. Not for human or veterinary use. Not a drug, food, or cosmetic. These statements have not been evaluated by the US Food and Drug Administration.





